wr 1065 has been researched along with carboplatin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holwerda, U; Klein, I; Pinedo, HM; Treskes, M; van der Vijgh, WJ | 1 |
Berens, ME; Dougherty, DV; Doz, F; Rosenblum, ML; Spencer, DR | 1 |
Eeltink, CM; Korst, AE; van der Vijgh, WJ; Vermorken, JB | 1 |
Berthold, F; Fichtner, I; Fulda, S; Hero, B | 1 |
Baruchel, S; Fouladi, M; Gammon, J; Grant, R; Greenberg, ML; Klein, J; Koren, G; Stempak, D | 1 |
3 trial(s) available for wr 1065 and carboplatin
Article | Year |
---|---|
Pharmacokinetics of amifostine and its metabolites in patients.
Topics: Adult; Amifostine; Antineoplastic Agents; Carboplatin; Cisplatin; Disulfides; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Mercaptoethylamines; Middle Aged | 1997 |
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays | 2001 |
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.
Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Mercaptoethylamines; Neoplasms; Treatment Failure | 2001 |
2 other study(ies) available for wr 1065 and carboplatin
Article | Year |
---|---|
The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.
Topics: Amifostine; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Interactions; Kinetics; Mercaptoethylamines; Radiation-Protective Agents | 1991 |
Experimental basis for increasing the therapeutic index of carboplatin in brain tumor therapy by pretreatment with WR compounds.
Topics: Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Carboplatin; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Mercaptoethylamines; Tumor Cells, Cultured | 1991 |